(Q40438856)

English

High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

High antibiotic resistance of Helicobacter pylori and its effect on tailored and empiric eradication of the organism in Lower Silesia, Poland (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Helicobacter pylori

0 references

antibiotic resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Stanisław Ferenc

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Jan Gnus

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Magdalena Kościelna

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Małgorzata Kinda

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Andriy Yarka

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Luke Stewart

6

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wojciech Witkiewicz

7

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

publication date

23 November 2016

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Helicobacter pylori and nonmalignant diseases

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Treatment of Helicobacter pylori Infection 2015.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Tailored versus Triple plus Bismuth or Concomitant Therapy as Initial Helicobacter pylori Treatment: A Randomized Trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Gastric cancer--epidemiologic and clinical aspects.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Systematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Tailored Therapy Versus Empiric Chosen Treatment for Helicobacter pylori Eradication: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

A new look at anti-Helicobacter pylori therapy

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication.

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Is There Any Difference in the Eradication Rate of Helicobacter pylori Infection According to the Endoscopic Stage of Peptic Ulcer Disease?

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Epidemiology of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1111%2FHEL.12365

21 January 2018

Identifiers

10.1111/HEL.12365

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40438856&oldid=1897820324"